Skip to content
Screener

Praxis Precision Medicines, Inc. PRAX Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$55.8M+13.5%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$5.39M-26.1%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$2.49M-34.9%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$8.73M-21.0%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
4.9%0.0pp
Biogen logo
BiogenBIIB
$245.7M-26.5%

Other financials

Income statement

See full
Revenue--100%
Operating income-$96.9M-27.4%
Net income-$83.7M-17.7%
EPS (diluted)-$2.87+13.3%

Balance sheet

See full
Cash & equivalents$474.8M+201%
Total debt$1.1M+44.0%
Total equity$1.3B+232%
Total assets$1.4B+207%

Cash flow

See full
Operating cash flow-$77.5M-41.8%
CapEx$245.0K+338%
Free cash flow-$77.8M-42.1%

Valuation

See full
Market cap$10.32B+909%
Enterprise value$9.85B+1,037%

Profitability

See full
Operating margin-3,927.5%-1,497pp
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-38.9%-10.3pp
Debt / equity0.0×
Current ratio15.7×+9.4×

Where this comes from

Reported directly by Praxis Precision Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:32 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001689548-26-000083
Line itemJune 30, 2026December 31, 2025
Total current assets771,903610,911
Long-term marketable securities615,290326,757
Property and equipment, net492147
Operating lease right-of-use assets1,00192
Internal-use software773
Other assets643
Total assets$1,390,102$937,907
Liabilities and stockholders’ equity

Item 1. Financial Statements (Unaudited)

FAQ

What is Praxis Precision Medicines, Inc.'s operating lease ROU assets?
Praxis Precision Medicines, Inc. (PRAX) reported operating lease ROU assets of $1M in Q2 2026.
How has Praxis Precision Medicines, Inc.'s operating lease ROU assets changed year-over-year?
Praxis Precision Medicines, Inc.'s operating lease ROU assets increased by 59.9% year-over-year, from $626K to $1M.
What is the long-term trend for Praxis Precision Medicines, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s operating lease ROU assets has grown at a -34.3% compound annual growth rate (CAGR), from $754K to $92K.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Praxis Precision Medicines, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude